United Therapeutics Corporation
UTHR
$301.42
-$6.58-2.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.32B | 3.27B | 3.33B | 2.97B | 2.71B |
| Total Receivables | 322.00M | 279.30M | 341.80M | 335.70M | 307.30M |
| Inventory | 165.40M | 157.90M | 146.70M | 136.50M | 120.20M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 131.10M | 169.70M | 185.40M | 175.80M | 113.40M |
| Total Current Assets | 3.94B | 3.87B | 4.00B | 3.62B | 3.25B |
|
|
|||||
| Total Current Assets | 3.94B | 3.87B | 4.00B | 3.62B | 3.25B |
| Net Property, Plant & Equipment | 1.30B | 1.22B | 1.16B | 1.09B | 1.07B |
| Long-term Investments | -- | 32.30M | -- | -- | -- |
| Goodwill | -- | 32.30M | -- | -- | -- |
| Total Other Intangibles | 111.70M | 79.60M | 112.10M | 115.20M | 115.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 620.00M | 621.50M | 545.50M | 534.50M | 536.70M |
| Total Assets | 7.74B | 7.36B | 7.12B | 6.72B | 6.50B |
|
|
|||||
| Total Accounts Payable | 367.00M | 6.00M | 363.90M | 325.30M | 305.10M |
| Total Accrued Expenses | -- | 380.30M | 29.40M | 29.20M | 29.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 200.00M | 306.10M | 400.00M | 400.00M | 400.00M |
| Total Finance Division Other Current Liabilities | 154.50M | 45.70M | 80.10M | 77.80M | 126.30M |
| Total Other Current Liabilities | 154.50M | 45.70M | 80.10M | 77.80M | 126.30M |
| Total Current Liabilities | 721.50M | 738.10M | 873.40M | 832.30M | 860.60M |
|
|
|||||
| Total Current Liabilities | 721.50M | 738.10M | 873.40M | 832.30M | 860.60M |
| Long-Term Debt | -- | -- | -- | 100.00M | 200.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 32.50M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 215.20M | 149.40M | 148.80M | 93.70M | 96.50M |
| Total Liabilities | 936.70M | 920.00M | 1.02B | 1.03B | 1.16B |
|
|
|||||
| Common Stock & APIC | 2.74B | 2.70B | 2.65B | 2.54B | 2.41B |
| Retained Earnings | 7.54B | 7.22B | 6.92B | 6.61B | 6.33B |
| Treasury Stock & Other | -3.48B | -3.48B | -3.47B | -3.46B | -3.40B |
| Total Common Equity | 6.81B | 6.44B | 6.10B | 5.70B | 5.34B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.81B | 6.44B | 6.10B | 5.70B | 5.34B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.81B | 6.44B | 6.10B | 5.70B | 5.34B |
|
|
|||||